tradingkey.logo
tradingkey.logo
Search

Exagen Inc

XGN
Add to Watchlist
4.530USD
-0.140-3.00%
Close 07-31 16:00ETQuotes delayed by 15 min
109.12MMarket Cap
LossP/E TTM

XGN Financials

See Exagen Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Exagen Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/-0.19
Revenue / Forecast
--/17.82M
Period
FY2025 Earnings
Revenue(YoY)
66.58M
19.65%
EPS(YoY)
-0.93
-11.45%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
17.75%-0.17
2.96%-0.20
-12.16%-0.31
-29.03%-0.21
-7.98%-0.20
34.68%-0.20
10.01%-0.28
42.54%-0.16
57.31%-0.19
62.57%-0.31
---0.31
---0.28
---0.44
---0.83
---1.94
----
----
----
----
----
Revenue
11.67%17.31M
21.79%16.63M
37.87%17.24M
14.19%17.20M
7.51%15.50M
-0.80%13.65M
-6.78%12.51M
6.56%15.06M
28.36%14.41M
7.23%13.77M
-8.90%13.42M
85.87%14.14M
8.04%11.23M
1.17%12.84M
20.20%14.73M
-40.45%7.61M
-1.82%10.39M
0.17%12.69M
13.70%12.25M
42.74%12.77M
Net Profit
-5.73%-3.97M
-24.25%-4.67M
-40.95%-7.09M
-49.66%-4.44M
-11.67%-3.75M
32.51%-3.76M
7.15%-5.03M
40.83%-2.97M
56.30%-3.36M
61.17%-5.57M
33.12%-5.42M
65.82%-5.01M
25.16%-7.69M
-103.52%-14.35M
-12.77%-8.10M
-128.78%-14.66M
-65.44%-10.27M
-104.26%-7.05M
-66.64%-7.18M
-90.60%-6.41M
Net Margin
5.32%-22.92%
-2.02%-28.10%
-2.23%-41.10%
-31.06%-25.81%
-3.86%-24.21%
31.97%-27.54%
0.40%-40.20%
44.47%-19.69%
65.95%-23.31%
63.79%-40.49%
---40.36%
---35.46%
---68.46%
---111.82%
---100.94%
----
----
----
----
----
Gross Margin
0.17%58.97%
-10.83%55.35%
4.67%58.43%
0.52%60.43%
-1.31%58.87%
4.91%62.08%
-2.82%55.82%
2.38%60.12%
26.29%59.65%
16.36%59.17%
--57.44%
--58.72%
--47.23%
--50.85%
--45.29%
----
----
----
----
----
Debt to assets ratio
-4.54%49.61%
-2.80%44.81%
-11.39%41.73%
-6.47%39.10%
32.18%51.97%
29.05%46.10%
43.55%47.10%
34.13%41.81%
3.85%39.31%
0.94%35.72%
--32.81%
--31.17%
--37.86%
--35.39%
--29.24%
----
----
----
----
----
Revenue
11.67%17.31M
21.79%16.63M
37.87%17.24M
14.19%17.20M
7.51%15.50M
-0.80%13.65M
-6.78%12.51M
6.56%15.06M
28.36%14.41M
7.23%13.77M
-8.90%13.42M
85.87%14.14M
8.04%11.23M
1.17%12.84M
20.20%14.73M
-40.45%7.61M
-1.82%10.39M
0.17%12.69M
13.70%12.25M
42.74%12.77M
Operating profit
-1.46%-3.41M
-47.06%-4.97M
33.52%-3.10M
-1.66%-2.63M
-12.05%-3.37M
34.27%-3.38M
8.01%-4.66M
47.37%-2.59M
61.03%-3.00M
42.72%-5.15M
35.15%-5.07M
65.05%-4.92M
20.38%-7.71M
-43.67%-8.98M
-20.19%-7.82M
-144.93%-14.06M
-73.86%-9.68M
-126.51%-6.25M
-71.79%-6.50M
-68.04%-5.74M
Net Profit
-5.73%-3.97M
-24.25%-4.67M
-40.95%-7.09M
-49.66%-4.44M
-11.67%-3.75M
32.51%-3.76M
7.15%-5.03M
40.83%-2.97M
56.30%-3.36M
61.17%-5.57M
33.12%-5.42M
65.82%-5.01M
25.16%-7.69M
-103.52%-14.35M
-12.77%-8.10M
-128.78%-14.66M
-65.44%-10.27M
-104.26%-7.05M
-66.64%-7.18M
-90.60%-6.41M
Current assets
34.08%43.58M
34.12%48.89M
47.90%52.59M
24.98%50.99M
-23.34%32.51M
-23.80%36.45M
-27.30%35.56M
-20.43%40.79M
-35.48%42.40M
-34.11%47.84M
-40.40%48.91M
-41.85%51.27M
-36.59%65.72M
-35.59%72.61M
-30.68%82.06M
-29.20%88.16M
-19.89%103.64M
59.87%112.73M
63.16%118.38M
69.51%124.53M
Total current liabilities
-10.23%12.56M
4.83%14.16M
46.86%12.89M
8.99%10.29M
59.34%13.99M
13.48%13.51M
-13.26%8.78M
9.80%9.45M
-5.23%8.78M
23.68%11.90M
-10.70%10.12M
-14.43%8.60M
-22.01%9.27M
3.27%9.62M
39.97%11.33M
21.65%10.05M
50.74%11.88M
6.24%9.32M
-2.15%8.10M
43.61%8.27M
Total assets
28.94%51.96M
29.84%58.02M
44.07%62.82M
19.17%58.76M
-20.69%40.29M
-21.52%44.69M
-28.43%43.60M
-23.17%49.31M
-35.88%50.81M
-33.96%56.94M
-40.03%60.93M
-39.94%64.18M
-35.08%79.23M
-30.15%86.22M
-20.49%101.60M
-19.86%106.85M
-11.25%122.04M
57.51%123.44M
59.73%127.77M
65.59%133.32M
Total liabilities
10.72%37.52M
15.43%40.57M
45.38%44.69M
18.93%37.73M
9.98%33.89M
2.62%35.15M
-8.04%30.74M
-1.72%31.72M
-28.82%30.82M
-21.73%34.25M
-26.40%33.42M
-26.69%32.28M
-5.65%43.30M
13.64%43.76M
22.84%45.41M
19.17%44.02M
27.28%45.89M
5.40%38.51M
4.08%36.97M
13.07%36.94M
Total equity
125.39%14.43M
82.90%17.45M
40.95%18.14M
19.61%21.03M
-67.97%6.40M
-57.96%9.54M
-53.21%12.87M
-44.88%17.59M
-44.37%19.99M
-46.55%22.69M
-51.05%27.50M
-49.22%31.90M
-52.81%35.94M
-50.01%42.46M
-38.12%56.19M
-34.82%62.82M
-24.95%76.16M
103.01%84.94M
104.17%90.80M
101.46%96.38M
Net operating income
2.38%-10.42M
-930.03%-3.01M
235.29%2.94M
-18.92%-2.88M
-18.04%-10.67M
-95.65%363.00K
25.17%-2.18M
76.11%-2.43M
7.27%-9.04M
245.61%8.35M
56.48%-2.91M
8.97%-10.15M
-13.70%-9.75M
5.18%-5.73M
-22.38%-6.68M
-150.65%-11.15M
-98.84%-8.57M
-55.09%-6.05M
-156.58%-5.46M
6.43%-4.45M
Net investment
-113.08%-228.00K
76.03%-35.00K
-87.07%-275.00K
-53.68%-209.00K
-24.42%-107.00K
-73.81%-146.00K
-7250.00%-147.00K
57.76%-136.00K
78.28%-86.00K
79.31%-84.00K
99.77%-2.00K
83.45%-322.00K
63.57%-396.00K
61.84%-406.00K
-85.05%-879.00K
-172.55%-1.95M
-550.90%-1.09M
-21180.00%-1.06M
-123.00%-475.00K
-366.67%-714.00K
Net financing
3.13%-62.00K
-77.78%-384.00K
2538.02%2.95M
9804.87%21.93M
36.00%-64.00K
1.82%-216.00K
-12.04%-121.00K
97.79%-226.00K
-61.29%-100.00K
-27.17%-220.00K
-390.91%-108.00K
-3779.55%-10.24M
-106.67%-62.00K
18.78%-173.00K
-117.60%-22.00K
14.84%-264.00K
-100.05%-30.00K
-159.76%-213.00K
66.67%125.00K
-694.87%-310.00K

FAQs

What is the total revenue of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its total revenue reached 66.58M, with a year-on-year change of 55.64M.

What are the current assets of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its current assets were 48.89M, with a year-on-year change of 34.12.

What are the total assets of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its total assets of Exagen Inc were 58.02M, with a year-on-year change of 29.84.

What are the total liabilities of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its total liabilities of Exagen Inc were 40.57M, with a year-on-year change of 15.43.

What is the total equity of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its total equity of Exagen Inc was 17.45M, with a year-on-year change of 82.90.

What is the net operating income of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its net operating income of Exagen Inc was -14.07M, with a year-on-year change of -3.18.

What is the net investment of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its net investment of Exagen Inc was -626.00K, with a year-on-year change of -21.55.

What is the net financing of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its net financing of Exagen Inc was 24.43M, with a year-on-year change of 3785.52.

What is the Earnings Per Share (EPS) of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.93, with a year-on-year change of -11.45.

What is the net income of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its net income was -19.95M, with a year-on-year change of -31.99.

What is the net margin of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its net profit margin was -29.97, with a year-on-year change of -10.32.

What is the gross margin of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its gross margin was 58.28, with a year-on-year change of -2.07.

What is the debt-to-asset ratio of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its debt-to-asset ratio was 44.81, with a year-on-year change of -2.80.

What is the Return on Equity (ROE) of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its Return on Equity (ROE) was -147.85, with a year-on-year change of -57.65.

What is the Return on Assets (ROA) of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its Return on Assets (ROA) was -38.85, with a year-on-year change of -30.61.

What is the operating profit of Exagen Inc?

According to Exagen Inc's FY2025 earnings report, its operating profit was -14.07M, with a year-on-year change of -3.18.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.